CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...